Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration. 



tag:reuters.com,2023:binary_RC28G3A9AAW8-BASEIMAGE

The Hill

Washington

District of Columbia

United States

Patient groups call on Trump administration to let Medicare cover obesity drugs

Drugs are indicated to treat type 2 diabetes; use for weight loss has gained popularity around the world

Medicamentos são indicados para tratar diabetes tipo 2; uso para emagrecimento ganhou popularidade ao redor do mundo

Mounjaro ou Ozempic? Compare preços e princípios ativos

Globo

Roberto Irineu Marinho

Brazil

Mounjaro or Ozempic? Compare prices and active ingredients

Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity and diabetes drugs.

Ad Fontes Media

All Sides

Media Bias/Fact Check

CNBC

Roberts family

Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand

A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal that would allow Medicare to cover obesity medications.  Led by the Obesity Care Advocacy Network (OCAN), more than 70 organizations said in a statement that addressing, treating and managing obesity is key to making America healthier.  The…

Nexstar Media Group

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.

NBC News

Weight loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the drugs are approved for other chronic conditions

The Globe & Mail

The Woodbridge Company

Canada

Wider benefits of Ozempic, Wegovy put pressure on Canadian insurers to expand drug coverage

(Reuters) -Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound. The new lawsuits name Thrive Health and Wellness LLC and Valhalla Vitality LLC. Lilly said the companies were selling unapproved drugs and making false claims about […]

Medscape

Lilly Sues Two Medical Spas Over Copycat Weight-loss Drugs

President-elect Donald Trump has not backed down from insisting that the United States needs to acquire Greenland, a Danish territory, "for national security purposes."But Greenland Prime Minister Múte Egede maintains that Greenland "is not for sale," and Danish Prime Minister Mette Frederiksen has said the same thing.Trump is refusing to rule out the possibility of using military force against Denmark, a longtime U.S. ally and member of the Nor…

Alternet

John K. Byrne

Michael Rogers (publisher)

Why Trump’s Denmark tariff would send the price of drugs like Ozempic through the roof

The next 15 drugs up for negotiation will be released soon and may include a GLP-1.

Ars Technica

Advance Publications

Maker of weight-loss drugs to ask Trump to pause price negotiations: Report

The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty ImagesEli Lilly cut its revenue guidance on Tuesday as it said demand for its weight loss and diabetes drugs would not meet its lofty expectations.The drugmaker's shares dropped about 6% in early trading Tuesday.Eli Lilly said it now expects full-year 2024 revenue of about $45 billion. That's …

Jingletree

The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024.  Ore Huiying | Bloomberg | Getty Images 
Eli Lilly cut its revenue guidance on Tuesday as it said demand for its weight loss and diabetes drugs would not meet its lofty expectations. The drugmaker’s shares dropped more than 7% in midday trading Tuesday. Eli Lilly said it now expects full-year 2024 revenue of about $45 billio…

Weight loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics